InvestorsHub Logo

osu78OnFire

09/02/16 2:55 PM

#15372 RE: osu78OnFire #15370

Further more

in the pr from 8/1/16 it still states "The Company expects to complete the Phase 3 clinical trial in the third quarter of 2016"